Top Markets
#1 QuantixAI QuantixAI +63.61%
#2 GEKKO GEKKO +43.09%
#3 Versatize Coin Versatize Coin +39.99%
#4 UnifAI Network UnifAI Network +29.42%
#5 MowCat MowCat +29.40%
#6 Storj Storj +29.08%
#7 Pons Pons +28.88%
#8 Prom Prom +28.67%
#9 Kinesis Silver Kinesis Silver +23.94%
#10 Fake World Assets Fake World Assets +22.62%
Coin of the day
QuantixAI QuantixAI
設定
言語
日本
通貨
USD
テーマ
Vaxart, Inc. Vaxart, Inc.

Vaxart, Inc.

VXRT
株式のランク #20724
Vaxart, Inc. operates as a biotechnology firm currently in the clinical... Vaxart, Inc. operates as a biotechnology firm currently in the clinical development phase, concentrating its efforts on identifying and advancing novel oral recombinant protein vaccines. The company leverages its unique proprietary platform for delivering these oral vaccine solutions. Its diverse pipeline showcases several promising candidates: An oral tablet vaccine targeting norovirus, which is presently undergoing Phase Ib clinical assessment for both GI.1 and GII.4 strains. A seasonal influenza vaccine, now in Phase II clinical studies, designed to address H1 influenza infections. A vaccine candidate against respiratory syncytial virus (RSV). A coronavirus vaccine, also advancing through Phase II clinical trials for SARS-CoV-2. Beyond infectious diseases, Vaxart is also engaged in formulating therapeutic vaccines aimed at treating cervical cancer and dysplasia associated with human papillomavirus. The company's main operations are situated in South San Francisco, California.
株価
$0.5106
時価総額
$123.59M
変化（1日）
-1.81%
変化（1年）
45.89%
国
US
取引 Vaxart, Inc. (VXRT)

カテゴリー

Healthcare
Vaxart, Inc.（VXRT）の利益
2026 時点の利益 TTM: 0
Vaxart, Inc. の最新の財務報告によると、同社の現在の利益は 0 です。2026 年には 0 の利益を上げ、これは 2026 年の利益 0 と 同等 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Vaxart, Inc. の利益の推移（2026 〜 2026）
各年末の利益
年 利益 変化
提供された日付のデータは十分ではありません。
同業他社の利益
企業 利益 利益の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH